Related Experiment Video
Updated: Jul 29, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
New directions in thrombolytic therapy.
1Product Development, Amgen Inc., Thousand Oaks, CA 91320, USA. ctoombs@amgen.com
Current Opinion in Pharmacology
|November 21, 2001
Summary
New fibrinolytic agents offer improved administration and reduced bleeding risk compared to current therapies. Research explores advanced antiplatelet combinations for better patient outcomes in thrombolytic treatment.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Hematology
Background:
- Current thrombolytic agents provide clinical benefits but have limitations.
- Challenges include incomplete reperfusion and bleeding risks.
- Advancements are needed to improve thrombolytic therapy efficacy and safety.
Purpose of the Study:
- To review recent advancements in thrombolytic therapy.
- To highlight new agents and treatment strategies.
- To discuss the evolving landscape of fibrinolytic and antiplatelet treatments.
Main Methods:
- Review of recent literature and regulatory approvals.
- Analysis of new therapeutic agents and combinations.
- Exploration of advanced antiplatelet therapies.
Main Results:
- Regulatory approval of thrombolytic agents with easier administration.
- Development of novel fibrinolytic agents.
- Investigation of combined thrombolytic and advanced antiplatelet therapies.
- Availability of a new class of directly acting fibrinolytic agents.
Conclusions:
- Recent innovations have improved thrombolytic therapy administration and safety.
- New agents and combination therapies show promise for enhanced reperfusion and reduced bleeding.
- The field is rapidly evolving with new therapeutic options.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...